Unrecognized Tax Benefits of Theravance Biopharma, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Theravance Biopharma, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Theravance Biopharma, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2024 was $83,658,000, a 5.3% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Theravance Biopharma, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $83,658,000 +$4,188,000 +5.3% 31 Dec 2024 10-K 07 Mar 2025 2024 FY
Q4 2023 $79,470,000 +$3,471,000 +4.6% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q4 2022 $75,999,000 +$976,000 +1.3% 31 Dec 2022 10-K 07 Mar 2025 2024 FY
Q3 2022 $62,661,000 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q4 2021 $75,023,000 +$11,576,000 +18% 31 Dec 2021 10-K 01 Mar 2024 2023 FY
Q4 2020 $63,447,000 +$4,684,000 +8% 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q4 2019 $58,763,000 +$6,359,000 +12% 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q4 2018 $52,404,000 +$10,610,000 +25% 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q4 2017 $41,794,000 +$18,540,000 +80% 31 Dec 2017 10-K 27 Feb 2020 2019 FY
Q4 2016 $23,254,000 +$14,056,000 +153% 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q4 2015 $9,198,000 +$8,139,000 +769% 31 Dec 2015 10-K 28 Feb 2018 2017 FY
Q3 2015 $2,400,000 +$2,000,000 +500% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 $1,900,000 +$1,900,000 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 $1,400,000 31 Mar 2015 10-Q 13 May 2015 2015 Q1
Q4 2014 $1,059,000 +$1,018,000 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $400,000 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 $0 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q4 2013 $41,000* 31 Dec 2013 10-K 01 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.